Global regenerative medicine market is expected to register a double digit CAGR through 2025 owing to their increasing use in repair, replacement or regeneration of cells, tissues and organs. Additionally, high prevalence of chronic & genetic dieses, emergence of stem cell technology and growing aging populations are some of the key factors driving the regenerative medicine market.

Regenerative medicines deal with process of replacing, engineering or regenerating human or animal cells, tissues or organs to restore or establish normal function. They are also being used to create solutions for organs that become permanently damaged. These medicines are also used in treatment of some uncurable dieses like arthritis and diabetes.

Increasing number of cancer patients, neurodegenerative, orthopedic, and other aging-associated disorders is creating a significant demand for regenerative medicine market globally. Various countries like United States, China and Japan are investing in stem cell research, which indicates a bright future for regenerative medicine manufacturers.

The global regenerative medicine market also faces some restraints like high treatment costs, stringent government regulations and operative inefficiency. High investment required for developing the medicine might also limit the market growth.

The market is segmented based on therapy, application, material, cell, product, technique, distribution channel and region. The application segment comprises of musculoskeletal disorders, wound care, oncology, neurology, ocular disorders, diabetes, cardiology and others. Out of them, the musculoskeletal segment is expected to dominate the market during the forecast years owing to growing use of regenerative medicines for treating musculoskeletal disorders and increasing number of orthopedic diseases. Based on material, the regenerative medicine market is segmented into synthetic material, biologically derived material, genetically engineered material and pharmaceutical. The biologically derived material dominated the regenerative medicine market in 2019 and is expected to further hold its position in the coming years due to its unique properties. This type of material promotes cellular interactions, increases proliferation and controls the manipulation of cellular behavior.

Major players operating in the global regenerative medicine market include Novartis AG, Vericel, Integra Lifesciences, Mimedx Group, Stryker, Wright Medical, Roche, Bristol-Myers Squibb, Allergan, Corline Biomedical, Cook Biotech, Pfizer, Baxter, Boehringer Ingelheim, Caladrius Biosciences, Takara Bio, Medtronic, Osiris Therapeutics, Kite Pharma, Organogenesis and others. Due to growing demand from Asia-Pacific region, the manufacturers are focusing on countries like India and China where geriatric population is increasing rapidly.

Years considered for this report:

Historical Years: 2015-2018

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2021–2025

Objective of the Study:

  • To analyze and forecast the market size of global regenerative medicine market.
  • To classify and forecast global regenerative medicine market based on therapy, application, material, cell, product, technique, distribution channel and regional distribution.
  • To identify drivers and challenges for global regenerative medicine market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global regenerative medicine market.
  • To conduct pricing analysis for global regenerative medicine market.
  • To identify and analyze the profile of leading players operating in global regenerative medicine market.


Click here to download the sample

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufacturers, distribution channels and presence of all major players across the globe.

TechSci Research calculated the market size of global regenerative medicine market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.


Key Target Audience:

  • Regenerative medicine manufacturers, suppliers, distributors and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to regenerative medicines
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers, partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, global regenerative medicine market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Market, By Therapy:
    • Cell-Based Immunotherapy & Cell Therapy
    • Gene Therapy
    • Tissue-Engineering
    • Immunomodulation Therapy
    • Blood Transfusion
    • Bone Marrow Transplantation
    • Plasma Rich Plasma Therapy
    • Prolotherapy
    • Others
  • Market, By Application:
    • Musculoskeletal Disorders
    • Wound Care
    • Oncology
    • Neurology
    • Ocular Disorders
    • Diabetes
    • Cardiology
    • Others

·       Market, By Material:

    • Synthetic Material
      • Biodegradable Synthetic Polymers
      • Scaffold
      • Artificial Vascular Graft Materials
      • Hydrogel Materials
    • Biologically Derived Material
      • Collagen
      • Xenogeneic Material
    • Genetically Engineered Material
      • Genetically Manipulated Cells
      • 3D Polymer Technology
      • Transgenic
      • Fibroblast
      • Neural Stem Cells
      • Gene-activated Matrices
    • Pharmaceutical
      • Small Molecules
    • Biologics
  • Market, By Cell:
    • Autologous
    • Allogenic
  • Market, By Product:
    • Biologic
    • Cell -based Medical Devices
    • Biopharmaceutical
    • Biomaterial
  • Market, By Technique:
    • Microfracture
    • Mosaicplasty
  • Market, By Distribution Channel:
    • Hospitals
    • Clinics
    • Online
    • Others
  • Market, By Region:
    • North America
      • United States
      • Canada
      • Mexico
    • Europe
      • Germany
      • France
      • United Kingdom
      • Italy
      • Spain
    • Asia-Pacific
      • China
      • Japan
      • India
      • South Korea
      • Australia
    • Middle East & Africa
      • South Africa
      • Saudi Arabia
      • UAE
    • South America
      • Brazil
      • Argentina
      • Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global regenerative medicine market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).
It is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at sales@techsciresearch.com  

In case you don’t find what you are looking for, please get in touch with our custom research team at sales@techsciresearch.com

1.    Product Overview

2.    Research Methodology

3.    Impact of COVID-19 on Global Regenerative Medicine Market

4.    Executive Summary

5.    Voice of Customer

6.    Global Regenerative Medicine Market Outlook

6.1.  Market Size & Forecast

6.1.1.     By Value & Volume

6.2.  Market Share & Forecast

6.2.1.     By Therapy (Cell-Based Immunotherapy & Cell Therapy, Gene Therapy, Tissue-Engineering, Immunomodulation therapy, Blood transfusion, Bone marrow transplantation, Plasma rich plasma therapy, Prolotherapy, Others)

6.2.2.     By Application (Musculoskeletal Disorders, Wound Care, Oncology, Neurology, Ocular Disorders, Diabetes, Cardiology, Others)

6.2.3.     By Material (Synthetic Material, Biologically Derived Material, Genetically Engineered Material, Pharmaceutical)

6.2.3.1.         By Synthetic Material (Biodegradable Synthetic Polymers, Scaffold, Artificial Vascular Graft Materials, Hydrogel Materials)

6.2.3.2.         By Biologically Derived Material (Collagen, Xenogeneic Material)

6.2.3.3.         By Genetically Engineered Material (Genetically Manipulated Cells, 3D Polymer Technology, Transgenic, Fibroblast, Neural Stem Cells, Gene-activated Matrices)

6.2.3.4.         By Pharmaceutical (Small Molecules, Biologics)

6.2.4.     By Cell (Autologous, Allogenic)

6.2.5.     By Product (Biologic, Cell -based Medical Devices, Biopharmaceutical, Biomaterial)

6.2.6.     By Technique (Microfracture, Mosaicplasty)

6.2.7.     By Distribution Channel (Hospitals, Clinics, Online, Others)

6.2.8.     By Region

6.2.9.     By Company

7.    North America Regenerative Medicine Market Outlook

7.1.  Market Size & Forecast          

7.1.1.     By Value & Volume

7.2.  Market Share & Forecast

7.2.1.     By Therapy

7.2.2.     By Application

7.2.3.     By Material

7.2.4.     By Cell

7.2.5.     By Product

7.2.6.     By Technique

7.2.7.     By Distribution Channel

7.2.8.     By Country (United States; Canada; Mexico and Rest of North America)

7.3.  North America: Country Analysis

7.3.1.     United States Regenerative Medicine Market Outlook

7.3.1.1.         Market Size & Forecast

7.3.1.1.1.             By Value & Volume

7.3.1.2.         Market Share & Forecast

7.3.1.2.1.             By Therapy

7.3.1.2.2.             By Application

7.3.1.2.3.             By Material

7.3.1.2.4.             By Cell

7.3.1.2.5.             By Product

7.3.1.2.6.             By Technique

7.3.1.2.7.             By Distribution Channel

7.3.2.     Canada Regenerative Medicine Market Outlook

7.3.2.1.         Market Size & Forecast

7.3.2.1.1.             By Value & Volume

7.3.2.2.         Market Share & Forecast

7.3.2.2.1.             By Therapy

7.3.2.2.2.             By Application

7.3.2.2.3.             By Material

7.3.2.2.4.             By Cell

7.3.2.2.5.             By Product

7.3.2.2.6.             By Technique

7.3.2.2.7.             By Distribution Channel

7.3.3.     Mexico Regenerative Medicine Market Outlook

7.3.3.1.         Market Size & Forecast

7.3.3.1.1.             By Value & Volume

7.3.3.2.         Market Share & Forecast

7.3.3.2.1.             By Therapy

7.3.3.2.2.             By Application

7.3.3.2.3.             By Material

7.3.3.2.4.             By Cell

7.3.3.2.5.             By Product

7.3.3.2.6.             By Technique

7.3.3.2.7.             By Distribution Channel

8.    Europe Regenerative Medicine Market Outlook

8.1.  Market Size & Forecast          

8.1.1.     By Value & Volume

8.2.  Market Share & Forecast

8.2.1.     By Therapy

8.2.2.     By Application

8.2.3.     By Material

8.2.4.     By Cell

8.2.5.     By Product

8.2.6.     By Technique

8.2.7.     By Distribution Channel

8.2.8.     By Country (United States; Canada; Mexico and Rest of North America)

8.3.  Europe: Country Analysis

8.3.1.     France Regenerative Medicine Market Outlook

8.3.1.1.         Market Size & Forecast

8.3.1.1.1.             By Value & Volume

8.3.1.2.         Market Share & Forecast

8.3.1.2.1.             By Therapy

8.3.1.2.2.             By Application

8.3.1.2.3.             By Material

8.3.1.2.4.             By Cell

8.3.1.2.5.             By Product

8.3.1.2.6.             By Technique

8.3.1.2.7.             By Distribution Channel

8.3.2.     Germany Regenerative Medicine Market Outlook

8.3.2.1.         Market Size & Forecast

8.3.2.1.1.             By Value & Volume

8.3.2.2.         Market Share & Forecast

8.3.2.2.1.             By Therapy

8.3.2.2.2.             By Application

8.3.2.2.3.             By Material

8.3.2.2.4.             By Cell

8.3.2.2.5.             By Product

8.3.2.2.6.             By Technique

8.3.2.2.7.             By Distribution Channel

8.3.3.     United Kingdom Regenerative Medicine Market Outlook

8.3.3.1.         Market Size & Forecast

8.3.3.1.1.             By Value & Volume

8.3.3.2.         Market Share & Forecast

8.3.3.2.1.             By Therapy

8.3.3.2.2.             By Application

8.3.3.2.3.             By Material

8.3.3.2.4.             By Cell

8.3.3.2.5.             By Product

8.3.3.2.6.             By Technique

8.3.3.2.7.             By Distribution Channel

8.3.4.     Italy Regenerative Medicine Market Outlook

8.3.4.1.         Market Size & Forecast

8.3.4.1.1.             By Value & Volume

8.3.4.2.         Market Share & Forecast

8.3.4.2.1.             By Therapy

8.3.4.2.2.             By Application

8.3.4.2.3.             By Material

8.3.4.2.4.             By Cell

8.3.4.2.5.             By Product

8.3.4.2.6.             By Technique

8.3.4.2.7.             By Distribution Channel

8.3.5.     Spain Regenerative Medicine Market Outlook

8.3.5.1.         Market Size & Forecast

8.3.5.1.1.             By Value & Volume

8.3.5.2.         Market Share & Forecast

8.3.5.2.1.             By Therapy

8.3.5.2.2.             By Application

8.3.5.2.3.             By Material

8.3.5.2.4.             By Cell

8.3.5.2.5.             By Product

8.3.5.2.6.             By Technique

8.3.5.2.7.             By Distribution Channel

9.    Asia-Pacific Regenerative Medicine Market Outlook

9.1.  Market Size & Forecast          

9.1.1.     By Value & Volume

9.2.  Market Share & Forecast

9.2.1.     By Therapy

9.2.2.     By Application

9.2.3.     By Material

9.2.4.     By Cell

9.2.5.     By Product

9.2.6.     By Technique

9.2.7.     By Distribution Channel

9.2.8.     By Country (United States; Canada; Mexico and Rest of North America)

9.3.  Asia-Pacific: Country Analysis

9.3.1.     South Korea Regenerative Medicine Market Outlook

9.3.1.1.         Market Size & Forecast

9.3.1.1.1.             By Value & Volume

9.3.1.2.         Market Share & Forecast

9.3.1.2.1.             By Therapy

9.3.1.2.2.             By Application

9.3.1.2.3.             By Material

9.3.1.2.4.             By Cell

9.3.1.2.5.             By Product

9.3.1.2.6.             By Technique

9.3.1.2.7.             By Distribution Channel

9.3.2.     China Regenerative Medicine Market Outlook

9.3.2.1.         Market Size & Forecast

9.3.2.1.1.             By Value & Volume

9.3.2.2.         Market Share & Forecast

9.3.2.2.1.             By Therapy

9.3.2.2.2.             By Application

9.3.2.2.3.             By Material

9.3.2.2.4.             By Cell

9.3.2.2.5.             By Product

9.3.2.2.6.             By Technique

9.3.2.2.7.             By Distribution Channel

9.3.3.     Japan Regenerative Medicine Market Outlook

9.3.3.1.         Market Size & Forecast

9.3.3.1.1.             By Value & Volume

9.3.3.2.         Market Share & Forecast

9.3.3.2.1.             By Therapy

9.3.3.2.2.             By Application

9.3.3.2.3.             By Material

9.3.3.2.4.             By Cell

9.3.3.2.5.             By Product

9.3.3.2.6.             By Technique

9.3.3.2.7.             By Distribution Channel

9.3.4.     India Regenerative Medicine Market Outlook

9.3.4.1.         Market Size & Forecast

9.3.4.1.1.             By Value & Volume

9.3.4.2.         Market Share & Forecast

9.3.4.2.1.             By Therapy

9.3.4.2.2.             By Application

9.3.4.2.3.             By Material

9.3.4.2.4.             By Cell

9.3.4.2.5.             By Product

9.3.4.2.6.             By Technique

9.3.4.2.7.             By Distribution Channel

9.3.5.     Australia Regenerative Medicine Market Outlook

9.3.5.1.         Market Size & Forecast

9.3.5.1.1.             By Value & Volume

9.3.5.2.         Market Share & Forecast

9.3.5.2.1.             By Therapy

9.3.5.2.2.             By Application

9.3.5.2.3.             By Material

9.3.5.2.4.             By Cell

9.3.5.2.5.             By Product

9.3.5.2.6.             By Technique

9.3.5.2.7.             By Distribution Channel

10.  Middle East and Africa Printing Ink Market Outlook

10.1.              Market Size & Forecast

10.1.1.  By Value & Volume

10.2.              Market Share & Forecast

10.2.1.  By Therapy

10.2.2.  By Application

10.2.3.  By Material

10.2.4.  By Cell

10.2.5.  By Product

10.2.6.  By Technique

10.2.7.  By Distribution Channel

10.2.8.  By Country (United States; Canada; Mexico and Rest of North America)

10.3.              MEA: Country Analysis

10.3.1.  South Africa Regenerative Medicine Market Outlook

10.3.1.1.      Market Size & Forecast

10.3.1.1.1.           By Value & Volume

10.3.1.2.      Market Share & Forecast

10.3.1.2.1.           By Therapy

10.3.1.2.2.           By Application

10.3.1.2.3.           By Material

10.3.1.2.4.           By Cell

10.3.1.2.5.           By Product

10.3.1.2.6.           By Technique

10.3.1.2.7.           By Distribution Channel

10.3.2.  Saudi Arabia Regenerative Medicine Market Outlook

10.3.2.1.      Market Size & Forecast

10.3.2.1.1.           By Value & Volume

10.3.2.2.      Market Share & Forecast

10.3.2.2.1.           By Therapy

10.3.2.2.2.           By Application

10.3.2.2.3.           By Material

10.3.2.2.4.           By Cell

10.3.2.2.5.           By Product

10.3.2.2.6.           By Technique

10.3.2.2.7.           By Distribution Channel

10.3.3.  UAE Regenerative Medicine Market Outlook

10.3.3.1.      Market Size & Forecast

10.3.3.1.1.           By Value & Volume

10.3.3.2.      Market Share & Forecast

10.3.3.2.1.           By Therapy

10.3.3.2.2.           By Application

10.3.3.2.3.           By Material

10.3.3.2.4.           By Cell

10.3.3.2.5.           By Product

10.3.3.2.6.           By Technique

10.3.3.2.7.           By Distribution Channel

11.  South America Regenerative Medicine Market Outlook

11.1.              Market Size & Forecast

11.1.1.  By Value & Volume

11.2.              Market Share & Forecast

11.2.1.  By Therapy

11.2.2.  By Application

11.2.3.  By Material

11.2.4.  By Cell

11.2.5.  By Product

11.2.6.  By Technique

11.2.7.  By Distribution Channel

11.2.8.  By Country (United States; Canada; Mexico and Rest of North America)

11.3.              South America: Country Analysis

11.3.1.  Brazil Regenerative Medicine Market Outlook

11.3.1.1.      Market Size & Forecast

11.3.1.1.1.           By Value & Volume

11.3.1.2.      Market Share & Forecast

11.3.1.2.1.           By Therapy

11.3.1.2.2.           By Application

11.3.1.2.3.           By Material

11.3.1.2.4.           By Cell

11.3.1.2.5.           By Product

11.3.1.2.6.           By Technique

11.3.1.2.7.           By Distribution Channel

11.3.2.  Argentina Regenerative Medicine Market Outlook

11.3.2.1.      Market Size & Forecast

11.3.2.1.1.           By Value & Volume

11.3.2.2.      Market Share & Forecast

11.3.2.2.1.           By Therapy

11.3.2.2.2.           By Application

11.3.2.2.3.           By Material

11.3.2.2.4.           By Cell

11.3.2.2.5.           By Product

11.3.2.2.6.           By Technique

11.3.2.2.7.           By Distribution Channel

11.3.3.  Colombia Regenerative Medicine Market Outlook

11.3.3.1.      Market Size & Forecast

11.3.3.1.1.           By Value & Volume

11.3.3.2.      Market Share & Forecast

11.3.3.2.1.           By Therapy

11.3.3.2.2.           By Application

11.3.3.2.3.           By Material

11.3.3.2.4.           By Cell

11.3.3.2.5.           By Product

11.3.3.2.6.           By Technique

11.3.3.2.7.           By Distribution Channel

12.  Market Dynamics

12.1.              Drivers

12.2.              Challenges

13.  Market Trends & Developments

14.  Competitive Landscape

14.1.              Competition Outlook

14.2.              Company Profiles

14.2.1.  Novartis AG

14.2.2.  Vericel

14.2.3.  Integra Lifesciences

14.2.4.  Mimedx Group

14.2.5.  Stryker

14.2.6.  Wright Medical

14.2.7.  Roche

14.2.8.  Bristol-Myers Squibb

14.2.9.  Allergan

14.2.10.                Corline Biomedical

14.2.11.                Cook Biotech

14.2.12.                Pfizer

14.2.13.                Baxter

14.2.14.                Boehringer Ingelheim

14.2.15.                Caladrius Biosciences

14.2.16.                Takara Bio

14.2.17.                Medtronic

14.2.18.                Osiris Therapeutics

14.2.19.                Kite Pharma

14.2.20.                Organogenesis

15.  Strategic Recommendations

16.  About Us and Disclaimer

                                                                            (Note: The companies list can be customized based on the client requirements.)

In case you don’t find what you are looking for, please get in touch with our custom research team at sales@techsciresearch.com